• Investing Ideas
  • /
  • Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
100 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

1652

Fusen Pharmaceutical
HK$0.892.3%-34.1%HK$658.0mn/aPS1.1xn/a0%

1498

PuraPharm
HK$0.73-1.4%-32.4%HK$288.4mn/aPB1.9xn/a0%

2096

Simcere Pharmaceutical Group
HK$5.403.4%-40.3%HK$13.9bHK$8.64PE18xE24.4%3.2%

2142

HBM Holdings
HK$2.49-12.9%-68.2%HK$1.8bHK$7.76PS7.8xE20.7%n/a

2257

Sirnaomics
HK$6.8815.6%-87.7%HK$597.3mHK$72.19PS1909.3xS58.2%n/a

2096

Simcere Pharmaceutical Group
HK$5.403.4%-40.3%HK$13.9bHK$8.64PE18xE24.4%3.2%

9969

InnoCare Pharma
HK$4.639.7%-48.0%HK$9.4bHK$9.73PS10.2xE23.7%n/a

2162

Keymed Biosciences
HK$33.955.1%-44.2%HK$9.4bHK$58.39PS24.5xE-8.6%n/a

2257

Sirnaomics
HK$6.8815.6%-87.7%HK$597.3mHK$72.19PS1909.3xS58.2%n/a

460

Sihuan Pharmaceutical Holdings Group
HK$0.5711.8%-28.7%HK$5.3bn/aPS2.6xE117.7%0%

2162

Keymed Biosciences
HK$33.955.1%-44.2%HK$9.4bHK$58.39PS24.5xE-8.6%n/a

1093

CSPC Pharmaceutical Group
HK$6.487.1%-17.6%HK$76.8bHK$9.35PE12.1xE4.5%4.3%

460

Sihuan Pharmaceutical Holdings Group
HK$0.5711.8%-28.7%HK$5.3bn/aPS2.6xE117.7%0%

3347

Hangzhou Tigermed Consulting
CN¥34.7510.8%-47.4%CN¥47.8bCN¥42.94PE30.2xE19.5%1.0%

460

Sihuan Pharmaceutical Holdings Group
HK$0.5711.8%-28.7%HK$5.3bn/aPS2.6xE117.7%0%

2616

CStone Pharmaceuticals
HK$1.13-31.5%-72.1%HK$1.4bHK$3.87PS2.6xE34.1%n/a

8329

Shenzhen Neptunus Interlong Bio-technique
HK$0.14-7.1%-1.4%HK$241.6mn/aPE9.3xn/an/a

9969

InnoCare Pharma
HK$4.639.7%-48.0%HK$9.4bHK$9.73PS10.2xE23.7%n/a

3347

Hangzhou Tigermed Consulting
CN¥34.7510.8%-47.4%CN¥47.8bCN¥42.94PE30.2xE19.5%1.0%

3737

Zhongzhi Pharmaceutical Holdings
HK$1.15-5.7%0.9%HK$993.1mn/aPE5.6xn/a5.2%

2616

CStone Pharmaceuticals
HK$0.882.3%-72.6%HK$1.1bHK$3.45PS2.2xE56.9%n/a

2162

Keymed Biosciences
HK$33.955.1%-44.2%HK$9.4bHK$58.39PS24.5xE-8.6%n/a

1093

CSPC Pharmaceutical Group
HK$6.487.1%-17.6%HK$76.8bHK$9.35PE12.1xE4.5%4.3%

1093

CSPC Pharmaceutical Group
HK$6.487.1%-17.6%HK$76.8bHK$9.35PE12.1xE4.5%4.3%
Page 4 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.